Financial Architects (New Jersey)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Financial Architects (New Jersey)’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,500	Closed	-$10K	–	1202
2019 Q1	$10K	Sell	1,500 -500	-25%	-$3.32K	﹤0.01%	1078
2018 Q4	$14K	Hold	2,000	–	–	﹤0.01%	906
2018 Q3	$13K	Hold	2,000	–	–	﹤0.01%	1033
2018 Q2	$11K	Hold	2,000	–	–	﹤0.01%	957
2018 Q1	$10K	Hold	2,000	–	–	﹤0.01%	1065
2017 Q4	$9K	Sell	2,000 -800	-29%	-$4.44K	﹤0.01%	1167
2017 Q3	$18K	Buy	2,800 +500	+22%	+$3.15K	﹤0.01%	973
2017 Q2	$14K	Buy	2,300 +250	+12%	+$1.69K	﹤0.01%	1054
2017 Q1	$15K	Buy	+2,050	New	+$9.47K	﹤0.01%	1015

Other funds holding AUPH

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Financial Architects (New Jersey)'s AUPH Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2019, closing a stake of 1,500 shares — an estimated $10K sold.

Financial Architects (New Jersey) first reported a position in AUPH in Q1 2017 and held it in 9 quarters. The position peaked at $18K in Q3 2017. 73 funds tracked by Wall St. Rank hold AUPH as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Aurinia Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 1,500 Aurinia Pharmaceuticals shares in Q2 2019, an estimated $10K.
Financial Architects (New Jersey) first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 9 quarters.
Financial Architects (New Jersey)'s Aurinia Pharmaceuticals position peaked at $18K in Q3 2017.
73 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.